Cencora Reaffirms Guidance After Limited Walgreens Volume Shift
Cencora reaffirms $17.75–$17.95 FY2026 EPS after minor Walgreens volume shift. Analysts see just 3–3.5% impact as core prime vendor deal stays intact.
NOTRELOAD AI
Lumentum Beats Estimates, Hits Long-Term Target Early as Jefferies and Citi Reiterate $1,200 Buys
LITE reports robust Q4, lifts guidance, and reaches long-term model early.
Quantinuum Beats Estimates in First Public Earnings as Oracle Deal Signals Growing Quantum Demand
Quantinuum tops estimates in first public earnings, raises 2026 outlook, and partners with Oracle to deploy Helios quantum computer in the cloud.
Temasek Plans Bigger Stakes in Samsung and SK Hynix, Sending Shares Higher
Singapore’s Temasek is considering increasing its stakes in Samsung Electronics and SK Hynix through its internal investment team.
Wendy’s Shares Surge as Nelson Peltz Prepares Take-Private Bid
Trian Fund Management is preparing a take-private bid for Wendy’s, potentially backed by BlueFive Capital and Flynn Group in the coming weeks.
BofA Downgrades Bending Spoons Over Limited Debt Capacity for M&A
BofA cuts Bending Spoons to Underperform, citing only $7B debt capacity vs $18B implied M&A.